Xikang Cloud Hospital Holdings Inc. (HKG:9686)
1.000
+0.065 (6.95%)
Nov 13, 2026, 3:20 PM HKT
HKG:9686 Revenue
Xikang Cloud Hospital Holdings had revenue of 182.87M CNY in the half year ending June 30, 2026, with 2.04% growth. This brings the company's total for the last twelve months to 468.40M, down -6.49% year-over-year. In the year 2025, Xikang Cloud Hospital Holdings had annual revenue of 464.14M, down -7.45%. That makes Xikang Cloud Hospital Holdings the 25,560th largest company in the world by revenue and 1,511th in Hong Kong.
Revenue (ttm)
468.40M CNY
Revenue Growth
-6.49%
P/S Ratio
1.56
Revenue / Employee
646.07K CNY
Employees
725
Market Cap
841.88M HKD
Revenue by Segment
Fiscal year ended Dec 31, 2024 See the full HKG:9686 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 464.14M | -37.36M | -7.45% |
| Dec 31, 2024 | 501.50M | -36.22M | -6.74% |
| Dec 31, 2023 | 537.72M | -149.70M | -21.78% |
| Dec 31, 2022 | 687.42M | 73.11M | 11.90% |
| Dec 31, 2021 | 614.30M | 111.29M | 22.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dingdang Health Technology Group | 5.74B |
| HealthyWay | 2.10B |
| QingSong Health | 1.11B |
| Yidu Tech | 931.27M |
| Mediwelcome Healthcare Management & Technology | 660.22M |
| Zhejiang Taimei Medical Technology | 614.14M |
| AIROBO Platform Group | 548.81M |
| Sinohealth Technology Holdings | 499.52M |
Xikang Cloud Hospital Holdings News
- 2 months ago - Xikang Cloud Hospital Holdings Earnings release: H1 2026 - Filings
- 2 months ago - Xikang Cloud Hospital Holdings Quarterly report: H1 2026 - Filings
- 7 months ago - Xikang Cloud Hospital Holdings Earnings release: H2 2025 - Filings
- 7 months ago - Xikang Cloud Hospital Holdings Annual report: H2 2025 - Filings